Nitrogen

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which may contraindicate its use in certain patients or conditions. There are no reported teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Administration of Nitrogen should be conducted exclusively by or under the supervision of a licensed practitioner experienced in its use and administration. Practitioners must possess a thorough understanding of the indications, effects, dosages, methods, and frequency and duration of administration.

The route of administration is via respiratory inhalation. The active ingredient is Nitrogen, provided at a concentration of 995 mL in a 1 L container. It is essential that administration occurs in a well-ventilated area, adhering to appropriate safety precautions to ensure the safety of both the patient and the healthcare provider.

Contraindications

There are no specific contraindications identified for this product. However, it is essential to adhere to safety protocols. Users should not handle the product until all safety precautions have been thoroughly read and understood. Additionally, connections should not be changed or forced, as this may lead to improper use or safety hazards.

Warnings and Precautions

Administration of Nitrogen may pose significant hazards and is contraindicated in certain situations. It is imperative that this substance is used solely by or under the supervision of a licensed practitioner who possesses expertise in the use and administration of Nitrogen. This includes familiarity with its indications, effects, dosages, methods, frequency and duration of administration, as well as an understanding of the associated hazards, contraindications, side effects, and necessary precautions.

Warnings

Nitrogen is classified as a gas under pressure and may explode if subjected to heat. Additionally, it has the potential to displace oxygen in the environment, leading to rapid suffocation. The product also contains refrigerated gas, which can result in cryogenic burns or injuries if not handled properly.

General Precautions

Prior to handling Nitrogen, it is essential that all safety precautions are thoroughly read and understood. The substance should only be used and stored outdoors or in a well-ventilated area to mitigate risks. Personal protective equipment, including cold insulation gloves, a face shield, and eye protection, must be worn at all times during handling. A backflow preventive device should be utilized in the piping to prevent any potential hazards. It is critical to avoid changing or forcing connections and to always maintain the container in an upright position. Users are advised to read and adhere to the Safety Data Sheet (SDS) before use.

Emergency Medical Help Instructions

In the event of inhalation, it is crucial to remove the affected individual to fresh air and ensure they are comfortable for breathing. Medical advice and attention should be sought immediately.

Instructions for Skin Exposure

If Nitrogen comes into contact with the skin, it is important to thaw any frosted areas using lukewarm water without rubbing the affected area. Immediate medical advice and attention should be obtained to address any potential injuries.

Side Effects

Patients may experience serious adverse reactions associated with the use of this product. Notably, it may cause cryogenic burns or injury, which necessitates immediate medical attention. Additionally, there is a risk of oxygen displacement leading to rapid suffocation, underscoring the importance of proper handling and usage.

In the event of exposure, specific first aid measures should be taken. If the product is inhaled, it is crucial to remove the individual to fresh air and ensure they are comfortable for breathing. For skin exposure, affected areas should be thawed with lukewarm water; it is important not to rub the area. Immediate medical advice or attention should be sought in both scenarios to mitigate potential harm.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrogen in pediatric patients may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The administration of Nitrogen during pregnancy may pose potential risks and is generally considered hazardous or contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who has experience in its use and administration.

Healthcare professionals should be aware of the warnings associated with Nitrogen, which includes the presence of gas under pressure that may explode if heated. Additionally, Nitrogen can displace oxygen, leading to rapid suffocation, which poses significant risks to both the pregnant patient and the fetus. The refrigerated nature of the gas also raises concerns, as it may cause cryogenic burns or injury.

Given these risks, healthcare providers should exercise caution and consider alternative therapies when treating pregnant patients. The potential for adverse fetal outcomes necessitates a thorough risk-benefit assessment before administration.

Lactation

There are no specific warnings or recommendations regarding the use of Nitrogen in lactating mothers. Additionally, there are no specific warnings or recommendations concerning the use of Nitrogen during lactation. Therefore, healthcare professionals may consider the use of Nitrogen in nursing mothers on a case-by-case basis, as no adverse effects on breastfed infants have been documented in the available data.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the drug insert for Nitrogen. Healthcare professionals should exercise caution and consider individual patient factors when prescribing this medication to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on the clinical presentation.

Healthcare professionals are encouraged to report any cases of suspected overdosage to the relevant authorities to contribute to the ongoing assessment of the medication's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No specific postmarketing experience details have been reported. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who is experienced in its use and administration. This practitioner should be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the warning that Nitrogen contains gas under pressure, which may explode if heated. Additionally, it may displace oxygen and cause rapid suffocation. Therefore, healthcare providers must emphasize the importance of not handling Nitrogen until all safety precautions have been read and understood. It is crucial to use and store Nitrogen only outdoors or in a well-ventilated area.

Healthcare providers should instruct patients to use a backflow preventive device in the piping and to utilize only equipment rated for cylinder pressure. Patients should be reminded to close the valve after each use and when the cylinder is empty. They should also protect the Nitrogen container from sunlight when the ambient temperature exceeds 52°C (125°F) and to read and follow the Safety Data Sheet (SDS) before use.

In the event of inhalation, patients should be advised to remove themselves to fresh air and keep comfortable for breathing, while seeking medical advice or attention. Providers should also inform patients of the warning regarding the presence of refrigerated gas, which may cause cryogenic burns or injury. Patients should be instructed to wear cold insulation gloves, a face shield, and eye protection when handling Nitrogen.

Healthcare providers must caution patients against changing or forcing fit connections and to always keep the container in an upright position. In case of skin contact, patients should be advised to thaw frosted parts with lukewarm water without rubbing the affected area and to seek immediate medical advice or attention.

Storage and Handling

The product is supplied in a container that must be kept in an upright position at all times. It is essential to use and store the product exclusively outdoors or in a well-ventilated area to ensure safety and compliance with handling requirements.

To maintain product integrity, it is crucial to protect the container from sunlight when the ambient temperature exceeds 52°C (125°F). Users should wear appropriate personal protective equipment, including cold insulation gloves, a face shield, and eye protection, during handling.

Connections should not be changed or forced to fit, as this may compromise the container's integrity. After each use and when the container is empty, the valve must be closed to prevent any potential leaks. Users are advised to read and follow the Safety Data Sheet (SDS) prior to use to ensure safe handling and storage practices.

Additional Clinical Information

Administration of Nitrogen is conducted via the respiratory route through inhalation. Clinicians should be aware that the use of Nitrogen may pose hazards and is contraindicated in certain situations. It is essential that administration is performed only by or under the supervision of a licensed practitioner experienced in its use, who understands the indications, effects, dosages, methods, frequency, duration, and associated risks.

Patients should be counseled on the potential dangers of Nitrogen, including the risk of explosion if heated and the possibility of oxygen displacement leading to rapid suffocation. Safety precautions must be thoroughly understood before handling, including the necessity of using the gas outdoors or in well-ventilated areas, employing backflow preventive devices, and ensuring equipment is rated for cylinder pressure. After each use, the valve should be closed, and the gas should be protected from sunlight when temperatures exceed 52°C (125°F). In case of inhalation, individuals should be moved to fresh air and kept comfortable while seeking medical attention. For skin exposure, affected areas should be thawed with lukewarm water without rubbing, and immediate medical advice should be sought.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Gas and Supply Carolinas, LLC. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)